INTRODUCTION
============

Among the traditional surgical approaches for maxillofacial bone reconstruction, autologous bone grafting is the most widely used.^[@R1]^ However, autologous bone grafting requires harvesting bone from an unaffected area and inevitably causes donor-site morbidity.^[@R2]--[@R5]^

The emergence of 3-dimensional (3D) printing has helped overcome challenges related to obtaining and shaping the graft or implant. In fact, there have been various attempts to fabricate customized medical artificial implants using 3D printing technology.^[@R6],[@R7]^ However, most implantable materials used thus far are not biodegradable, which substantially increases the risk of inflammation, infection, and even implant protrusion.^[@R8],[@R9]^ To address these limitations, current efforts aim to facilitate regeneration or reconstruction of the defect area using 3D-printed scaffolds made of biodegradable and clinically safe polymers. Recently, 3D-printed, patient-tailored splints made of the biocompatible and biodegradable polymer polycaprolactone (PCL) were used to prevent airway stenosis in infants with tracheobronchomalacia.^[@R10],[@R11]^

In this context, we describe the fabrication and implantation of patient-specific, 3D-printed PCL scaffolds with fully interconnected pores for complicated craniomaxillofacial reconstruction.

PATIENTS AND METHODS
====================

Patient Characteristics
-----------------------

Patient 1 was a 43-year-old woman who had undergone left radial maxillectomy for minor salivary cancer in the left maxillary sinus and hard palate, with immediate reconstruction using a fibular osteocutaneous free flap. Patient 2 was a 45-year-old man who had been diagnosed with squamous cell carcinomas in the left maxillary sinus 8 years before presenting to our department. The patient had undergone radical maxillectomy and partial mandibulectomy, which resulted in severe facial deformity. Patient 3 was an 18-year-old man who had received right partial maxillectomy for chondrosarcoma 9 years before presenting to our department; the procedure had resulted in a medial maxilla defect on the right side of the face.

This study was approved by the Institutional Review Board and Ethics Committee of our center (approval No. KC14DNME0751). The 3D-printed scaffold was manufactured according to Good Manufacturing Practice provisions \[registration No. KTC-ABB-170177, approved by the South Korea Ministry of Food and Drug Safety (MFDS) and was registered as a medical device in South Korea (registration No. 14--1337, approved by the MFDS\].

Designing the Customized Scaffolds
----------------------------------

Customized PCL scaffolds were designed using commercial 3D medical image editing software (Materialise Mimics; Materialise NV, Leuven, Belgium). The patient's head was scanned using a computed tomography (CT) device, with a slice thickness of 1 mm. The side with the normal bony orbit was mirrored to the midsagittal plane, which was defined according to standardized bony landmarks (**see figure, Supplemental Digital Content 1**, which demonstrates designing the customized implant, <http://links.lww.com/PRSGO/A906>). Finally, patient-specific scaffolds were fabricated using a 3D-printing system (Fig. [1](#F1){ref-type="fig"}A).

![A, Evaluation of the patient-specific scaffold before reconstruction of a maxillary defect. The custom-designed 3D model of the scaffold is shown mounted on the model of the cranium generated using computer-aided design. B, Clinical photographs (preoperative and postoperative states) taken during the follow-up period. C, The calculated increase in HU as an indicator of tissue density. All of the calculations were based on CT image analysis of data collected preoperatively (Pre-op) and postoperatively (Post-op) at various intervals (in months, M). The bar height represents the mean, while the error bar indicates the SD.](gox-6-e1975-g001){#F1}

Fabrication of 3D-printed PCL Scaffolds
---------------------------------------

For use as tissue-regeneration scaffolds, fully customized scaffolds made of medical-grade PCL (Evonik Industries, Essen, Germany) were fabricated using the in-house 3D printer.^[@R12],[@R13]^ This process was performed in a facility with Good Manufacturing Practice certification (T&R Biofab Co. Ltd., Seoul, Korea) approved by the MFDS of Korea.

Surgical Procedures
-------------------

The PCL scaffold customized for each patient was inserted under general anesthesia. The maxillary defect was exposed through a simple incision. The implant was inserted, and the incision was closed without using an additional flap or tissue transfer (**see video, Supplemental Digital Content 2**, which demonstrates the surgical process for Patient 3. This video is available in the "Related Videos" section at PRSGlobalOpen.com or at <http://links.lww.com/PRSGO/A907>).

![See video, Supplemental Digital Content 2, which demonstrates the surgical process of patient 3. This video is available in the "Related Videos" section at PRSGlobalOpen.com or at <http://links.lww.com/PRSGO/A907>.](gox-6-e1975-g002){#V1}

CT Image Analysis
-----------------

The follow-up CT data were converted into 2D- or 3D-reconstructed images. The pre- and postoperative 3D images were overlapped to analyze the increase in soft-tissue volume after surgery.

Statistical Analysis
--------------------

The difference between mean values was evaluated using Student's *t* test, in which a *P* value \< 0.01 was considered to indicate significance.

RESULTS
=======

Clinical Outcomes
-----------------

The implanted scaffolds were well maintained during follow-up, without the occurrence of any complications, such as wound dehiscence or infection. Eye height with an acceptable degree of symmetry (compared with that noted preoperatively) was maintained throughout the follow-up period (Fig. [1](#F1){ref-type="fig"}B). The presence of neo-tissue ingrowth can be seen in **Supplemental Digital Content 3** (**see figure, Supplemental Digital Content 3**, which shows examples of the surgical outcomes for the patients, <http://links.lww.com/PRSGO/A908>).

CT-based Quantitative Analysis after Reconstruction
---------------------------------------------------

Overlapping the pre- and postoperative CT images revealed that reconstructive surgery achieved an increase of 2,711 mm^3^ in patient 1 at 16 months postoperatively (Fig. [1](#F1){ref-type="fig"}C). Measurement of Hounsfield unit values on CT images indicated that, tissue density (ie, the HU values) in the area where the scaffold was implanted increased significantly. In the preoperative state, the mean HU value was -76.269. After scaffold implantation, the HU values at 6 and 16 months postoperatively were 63.7825 and 73.0488, respectively.

DISCUSSION
==========

By adjusting the parameters of the 3D printing--based fabrication method, the customized scaffolds can be designed to have thoroughly interconnected 3D pores. In the present study, the scaffolds were fabricated with a reference pore size of 900 μm to promote tissue ingrowth. Follow-up evaluation revealed that the pores had indeed become filled with soft tissue, and the facial contour was well maintained. Considering that no signs of infection were observed in any of the patients after scaffold implantation, we believe that fusion with existing native tissue occurred successfully due to early vascularization and tissue filling within the pores.

PCL scaffolds, which have a degradation period of 2--3 years, are suitable for use as biocompatible tissue-engineered scaffolds and the induction of tissue regeneration, although they have a limited capacity to induce bone tissue ingrowth.^[@R14]--[@R16]^ Indeed, our CT-based analysis revealed increased tissue density, thus confirming soft-tissue ingrowth. It did not, however, indicate that bone tissue had regenerated within the PCL scaffold. To promote bone tissue regeneration, future studies should consider using a different material, such as blended PCL/beta-tricalcium phosphate (powder type) with an adequate pore size and seeding of relevant cells.^[@R13],[@R17],[@R18]^

CONCLUSIONS
===========

Complicated craniomaxillofacial defects can be reconstructed efficiently using 3D-printed, patient-specific scaffolds. We reported that customized, tissue-engineered scaffolds could be successfully fabricated using the patients' CT data and an extrusion-based 3D printing system. Moreover, biodegradable PCL polymer promoted regeneration of deficient tissue while remaining stable in the body for a relatively extended period.
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